ArticleLancet (London, England)2010
Dapagliflozin, an SGLT2 inhibitor, for diabetes.
Markolf Hanefeld et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it
ArticleLancet (London, England)2010
Markolf Hanefeld et al.PubMed ↗Publisher ↗
No numbers read from the abstract.